Recently, cannabidiol and tetrahydrocannabinol have been tested in a small cohort of patient with drug-resistant myotonia and myalgia in which they showed a beneficial antimyotonic effect achieved through Nav1.4 block [49]. Here, SCN4A is linked to Myotonia.